Dashboard
Manage Tickers

VRTXVERTEX PHARMACEUTICALS INC ...

Nasdaq vrtx.com


$ 480.92 $ 1.70 (0.35 %)    

Friday, 14-Jun-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 480.73
$ 477.80
$ 480.75 x 200
$ 480.91 x 200
$ 477.55 - $ 483.63
$ 335.82 - $ 486.43
641,768
na
125.52B
$ 0.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 10-28-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-13-2019 12-31-2018 10-K
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 10-30-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 04-28-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 10-31-2016 09-30-2016 10-Q
32 08-01-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 02-16-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 07-31-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
CNBC Halftime Report Final Trades: NVIDIA,...
06/14/2024 17:00:47

vertex-reveals-long-term-data-on-casgevy-exagamglogene-autotemcel-at-eha-2024-congress
Vertex Reveals Long-Term Data On CASGEVY (...
06/14/2024 08:14:10

alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday
Alphabet To Rally Over 28%? Here Are 10 To...
06/11/2024 12:53:07

rbc-capital-maintains-sector-perform-on-vertex-pharmaceuticals-lowers-price-target-to-421
RBC Capital Maintains Sector Perform on Ve...
06/11/2024 11:36:19

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and lowers the price...

arcturus-inhaled-mrna-therapeutic-in-cystic-fibrosis-study-highlights-potential-amid-competitive-landscape-analyst
Arcturus' Inhaled mRNA Therapeutic In Cyst...
06/07/2024 18:44:44

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, ...

vertex-to-present-new-data-demonstrating-significant-benefits-of-treatment-with-trikafta-at-the-ecfs-47th-european-cystic-fibrosis-conference-held-june-5-8-2024
Vertex To Present New Data Demonstrating S...
06/07/2024 16:03:01

- Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR m...

1000-invested-in-vertex-pharmaceuticals-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Vertex Pharmaceuticals 5...
06/05/2024 18:00:32

rbc-capital-reiterates-sector-perform-on-vertex-pharmaceuticals-maintains-424-price-target
RBC Capital Reiterates Sector Perform on V...
06/04/2024 13:50:18

RBC Capital analyst Brian Abrahams reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and maintains $424 ...

this-is-what-whales-are-betting-on-vertex-pharmaceuticals
This Is What Whales Are Betting On Vertex ...
06/03/2024 19:16:00

analyst-expectations-for-vertex-pharmaceuticalss-future
Analyst Expectations For Vertex Pharmaceut...
05/31/2024 15:01:19

bmo-capital-maintains-outperform-on-vertex-pharmaceuticals-raises-price-target-to-500
BMO Capital Maintains Outperform on Vertex...
05/31/2024 13:42:30

BMO Capital analyst Evan Seigerman maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and raises the price tar...

arcturus-therapeutics-early-cystic-fibrosis-trial-results-encouraging---analyst-cautiously-optimistic
Arcturus Therapeutics' Early Cystic Fibros...
05/28/2024 18:55:43

Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung ...

spotlight-on-vertex-pharmaceuticals-analyzing-the-surge-in-options-activity
Spotlight on Vertex Pharmaceuticals: Analy...
05/23/2024 19:46:09

slb-first-solar-and-2-other-stocks-insiders-are-selling
SLB, First Solar And 2 Other Stocks Inside...
05/23/2024 12:31:41

walmart-vertex-pharmaceuticals-and-more-on-cnbcs-final-trades
Walmart, Vertex Pharmaceuticals And More O...
05/23/2024 12:30:31

Walmart Inc. reported a "really strong" quarter, with e-commerce sales surging 21%. Adjusted EPS was 60 cents.

Core News & Articles
CNBC Halftime Report Final Trades: Walmart...
05/22/2024 17:01:02

vertex-pharmaceuticalss-options-frenzy-what-you-need-to-know
Vertex Pharmaceuticals's Options Frenzy: W...
05/15/2024 20:31:23

pfizer-freeport-mcmoran-vertex-pharmaceuticals-and-a-major-tech-stock-on-cnbcs-final-trades
Pfizer, Freeport-McMoRan, Vertex Pharmaceu...
05/15/2024 13:07:22

Pfizer is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform.

Core News & Articles
CNBC Halftime Report Final Trades: Pfizer,...
05/14/2024 17:00:33

heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-10-years
Here's How Much You Would Have Made Owning...
05/14/2024 14:00:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)